MultiBac turns sweet

Bioengineered

Volumn 4, Issue 2, 2013, Pages

  Palmberger, Dieter ^a   Klausberger, Miriam ^a   Berger, Imre ^b   Grabherr, Reingard ^a  

^a UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

Author keywords

Baculovirus; Glycosylation; Insect cells; MultiBac; SweetBac; Virus like particles

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; VIRUS LIKE PARTICLE VACCINE; VIRUS SIALIDASE; PROTEIN;

BACTERIAL ARTIFICIAL CHROMOSOME; BACULOVIRUS EXPRESSION SYSTEM; BACULOVIRUS VECTOR; DNA REPLICATION ORIGIN; GLYCOSYLATION; IMMUNOGENICITY; INSECT CELL; MODULATION; MULTIBAC TECHNOLOGY; PROTEIN EXPRESSION; REVIEW; SWEETBAC TECHNOLOGY; VACCINE PRODUCTION; ANIMAL; BACULOVIRUS; BIOENGINEERING; CYTOLOGY; GENE VECTOR; GENETICS; INSECT; INSECT CELLS; METABOLISM; METHODOLOGY; MULTIBAC; SWEETBAC; VIRUS-LIKE PARTICLES;

BACULOVIRUS; GLYCOSYLATION; INSECT CELLS; MULTIBAC; SWEETBAC; VIRUS-LIKE PARTICLES;

ANIMALS; BACULOVIRIDAE; BIOENGINEERING; GENETIC VECTORS; GLYCOSYLATION; INSECTS; PROTEINS;

EID: 84877719424     PISSN: 19491018     EISSN: 19491026     Source Type: Journal    
DOI: 10.4161/bioe.22327     Document Type: Review

References (35)

1. Schiller JT, Castellsagué X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine 2008; 26(Suppl 10):K53-61; PMID:18847557; http://dx.doi.org/10.1016/j.vaccine.2008.06.002.
2. Hashimoto Y, Zhang S, Blissard GW. Ao38, a new cell line from eggs of the black witch moth, Ascalapha odorata (Lepidoptera: Noctuidae), is permissive for AcMNPV infection and produces high levels of recombinant proteins. BMC Biotechnol 2010; 10:50; PMID:20602790; http://dx.doi.org/10.1186/1472-6750-10-50.
3. Summers MD, Smith GE. A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agricultural Experiment Station Bulletin 1987; 1555.
4. Vaughn JL, Goodwin RH, Tompkins GJ, McCawley P. The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera; Noctuidae). In Vitro 1977; 13:213-7; PMID:68913; http://dx.doi. org/10.1007/BF02615077.
5. Wickham TJ, Nemerow GR. Optimization of growth methods and recombinant protein production in BTI-Tn-5B1-4 insect cells using the baculovirus expression system. Biotechnol Prog 1993; 9:25-30; PMID:7764044; http://dx.doi.org/10.1021/bp00019a004.
6. Kost TA, Condreay JP, Jarvis DL. Baculovirus as versatile vectors for protein expression in insect and mammalian cells. Nat Biotechnol 2005; 23:567-75; PMID:15877075; http://dx.doi.org/10.1038/nbt1095.
7. Krammer F, Grabherr R. Alternative influenza vaccines made by insect cells. Trends Mol Med 2010; 16:313-20; PMID:20570562; http://dx.doi.org/10.1016/j. molmed.2010.05.002.
8. Krammer F, Nakowitsch S, Messner P, Palmberger D, Ferko B, Grabherr R. Swine-origin pandemic H1N1 influenza virus-like particles produced in insect cells induce hemagglutination inhibiting antibodies in BALB/c mice. Biotechnol J 2010; 5:17-23; PMID:20041443; http://dx.doi.org/10.1002/biot.200900267.
9. Krammer F, Schinko T, Palmberger D, Tauer C, Messner P, Grabherr R. Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. Mol Biotechnol 2010; 45:226-34; PMID:20300881; http://dx.doi.org/10.1007/s12033-010-9268-3.
10. Berger I, Fitzgerald DJ, Richmond TJ. Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol 2004; 22:1583-7; PMID:15568020; http://dx.doi.org/10.1038/nbt1036.
11. Bieniossek C, Richmond TJ, Berger I. MultiBac: multigene baculovirus-based eukaryotic protein complex production. Curr Protoc Protein Sci 2008; Chapter 5:Unit 5.20.
12. Fitzgerald DJ, Berger P, Schaffitzel C, Yamada K, Richmond TJ, Berger I. Protein complex expression by using multigene baculoviral vectors. Nat Methods 2006; 3:1021-32; PMID:17117155; http://dx.doi. org/10.1038/nmeth983.
13. Trowitzsch S, Bieniossek C, Nie Y, Garzoni F, Berger I. New baculovirus expression tools for recombinant protein complex production. J Struct Biol 2010; 172:45-54; PMID:20178849; http://dx.doi.org/10.1016/j. jsb.2010.02.010.
14. Senger T, Schädlich L, Gissmann L, Müller M. Enhanced papillomavirus-like particle production in insect cells. Virology 2009; 388:344-53; PMID:19409593; http://dx.doi.org/10.1016/j.virol.2009.04.004.
15. Possee RD, Sun TP, Howard SC, Ayres MD, Hill-Perkins M, Gearing KL. Nucleotide sequence of the Autographa californica nuclear polyhedrosis 9.4 kbp EcoRI-I and-R (polyhedrin gene) region. Virology 1991; 185:229-41; PMID:1926775; http://dx.doi. org/10.1016/0042-6822(91)90770-C.
16. Hom LG, Volkman LE. Autographa californica M nucleopolyhedrovirus chiA is required for processing of V-CATH. Virology 2000; 277:178-83; PMID:11062048; http://dx.doi.org/10.1006/viro.2000.0586.
17. Slack JM, Kuzio J, Faulkner P. Characterization of v-cath, a cathepsin L-like proteinase expressed by the baculovirus Autographa californica multiple nuclear polyhedrosis virus. J Gen Virol 1995; 76:1091-8; PMID:7730794; http://dx.doi.org/10.1099/0022-1317-76-5-1091.
18. Hitchman RB, Possee RD, Crombie AT, Chambers A, Ho K, Siaterli E, et al. Genetic modification of a baculovirus vector for increased expression in insect cells. Cell Biol Toxicol 2010; 26:57-68; PMID:19655260; http://dx.doi.org/10.1007/s10565-009-9133-y.
19. Luckow VA. Baculovirus systems for the expression of human gene products. Curr Opin Biotechnol 1993; 4:564-72; PMID:7764207; http://dx.doi. org/10.1016/0958-1669(93)90078-B.
20. Possee RD, Hitchman RB, Richards KS, Mann SG, Siaterli E, Nixon CP, et al. Generation of baculovirus vectors for the high-throughput production of proteins in insect cells. Biotechnol Bioeng 2008; 101:1115-22; PMID:18781697; http://dx.doi.org/10.1002/bit.22002.
21. Hitchman RB, Possee RD, Siaterli E, Richards KS, Clayton AJ, Bird LE, et al. Improved expression of secreted and membrane-targeted proteins in insect cells. Biotechnol Appl Biochem 2010; 56:85-93; PMID:20441568; http://dx.doi.org/10.1042/BA20090130.
22. Kang SM, Song JM, Quan FS, Compans RW. Influenza vaccines based on virus-like particles. Virus Res 2009; 143:140-6; PMID:19374929; http://dx.doi. org/10.1016/j.virusres.2009.04.005.
23. Krammer F, Schinko T, Palmberger D, Tauer C, Messner P, Grabherr R. Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines. Mol Biotechnol 2010; 45:226-34; PMID:20300881; http://dx.doi.org/10.1007/s12033-010-9268-3.
24. Latham T, Galarza JM. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol 2001; 75:6154-65; PMID:11390617; http://dx.doi.org/10.1128/JVI.75.13.6154-6165.2001.
25. Galarza JM, Latham T, Cupo A. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol 2005; 18:244-51; PMID:15802970; http://dx.doi. org/10.1089/vim.2005.18.244.
26. Pushko P, Pearce MB, Ahmad A, Tretyakova I, Smith G, Belser JA, et al. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes. Vaccine 2011; 29:5911-8; PMID:21723354; http://dx.doi.org/10.1016/j.vaccine.2011.06.068.
27. Ross TM, Mahmood K, Crevar CJ, Schneider-Ohrum K, Heaton PM, Bright RA. A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. PLoS One 2009; 4:e6032; PMID:19554101; http://dx.doi. org/10.1371/journal.pone.0006032.
28. Altmann F, Staudacher E, Wilson IB, März L. Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj J 1999; 16:109-23; PMID:10612411; http://dx.doi.org/10.1023/A:1026488408951.
29. Schulze IT. Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. J Infect Dis 1997; 176(Suppl 1):S24-8; PMID:9240690; http://dx.doi.org/10.1086/514170.
30. Jarvis DL, Finn EE. Modifying the insect cell N-glycosylation pathway with immediate early baculovirus expression vectors. Nat Biotechnol 1996; 14:1288-92; PMID:9631095; http://dx.doi. org/10.1038/nbt1096-1288.
31. Aumiller JJ, Hollister JR, Jarvis DL. A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins. Glycobiology 2003; 13:497-507; PMID:12626399; http://dx.doi.org/10.1093/glycob/cwg051.
32. Hollister J, Grabenhorst E, Nimtz M, Conradt H, Jarvis DL. Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans. Biochemistry 2002; 41:15093-104; PMID:12475259; http://dx.doi.org/10.1021/bi026455d.
33. Aumiller JJ, Mabashi-Asazuma H, Hillar A, Shi X, Jarvis DL. A new glycoengineered insect cell line with an inducibly-mammalianized protein N-glycosylation pathway. Glycobiology 2011; PMID:22042767.
34. Palmberger D, Rendic D, Tauber P, Krammer F, Wilson IB, Grabherr R. Insect cells for antibody production: evaluation of an efficient alternative. J Biotechnol 2011; 153:160-6; PMID:21477625; http://dx.doi. org/10.1016/j.jbiotec.2011.02.009.
35. Palmberger D, Wilson IBH, Berger I, Grabherr R, Rendic D. SweetBac: a new approach for the production of mammalianised glycoproteins in insect cells. PLoS One 2012; 7:e34226; PMID:22485160; http://dx.doi.org/10.1371/journal.pone.0034226.